- Home
- RLTY vs SMTI Comparison
RLTY vs SMTI Comparison
Compare RLTY & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLTY
- SMTI
- Stock Information
- Founded
- RLTY 2022
- SMTI 1982
- Country
- RLTY United States
- SMTI United States
- Employees
- RLTY N/A
- SMTI N/A
- Industry
- RLTY Investment Managers
- SMTI Medical/Dental Instruments
- Sector
- RLTY Finance
- SMTI Health Care
- Exchange
- RLTY Nasdaq
- SMTI Nasdaq
- Market Cap
- RLTY 251.8M
- SMTI 273.6M
- IPO Year
- RLTY N/A
- SMTI N/A
- Fundamental
- Price
- RLTY $15.19
- SMTI $28.50
- Analyst Decision
- RLTY
- SMTI Strong Buy
- Analyst Count
- RLTY 0
- SMTI 2
- Target Price
- RLTY N/A
- SMTI $49.50
- AVG Volume (30 Days)
- RLTY 86.7K
- SMTI 38.0K
- Earning Date
- RLTY 01-01-0001
- SMTI 08-11-2025
- Dividend Yield
- RLTY 9.35%
- SMTI N/A
- EPS Growth
- RLTY N/A
- SMTI N/A
- EPS
- RLTY N/A
- SMTI N/A
- Revenue
- RLTY N/A
- SMTI $91,569,883.00
- Revenue This Year
- RLTY N/A
- SMTI $23.53
- Revenue Next Year
- RLTY N/A
- SMTI $5.93
- P/E Ratio
- RLTY N/A
- SMTI N/A
- Revenue Growth
- RLTY N/A
- SMTI 34.65
- 52 Week Low
- RLTY $11.38
- SMTI $25.86
- 52 Week High
- RLTY $14.60
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- RLTY 53.64
- SMTI 44.50
- Support Level
- RLTY $14.91
- SMTI $27.80
- Resistance Level
- RLTY $15.23
- SMTI $28.50
- Average True Range (ATR)
- RLTY 0.22
- SMTI 1.09
- MACD
- RLTY -0.00
- SMTI 0.07
- Stochastic Oscillator
- RLTY 50.85
- SMTI 44.60
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.